Condition
Mesothelioma
Estimated Enrollment: 230
Age Group: 18 Years to 85 Years (Adult, Senior)
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Case-Only|Time Perspective: Retrospective
Study ID Numbers: 2010-280-1
Study First Received: January 6, 2014
Last Updated: January 6, 2014
Estimated Primary Completion Date: December 2010
Primary Outcome Measures:
Serum N-ERC/mesothelin, C-ERC/mesothelin, hyaluronan, osteopontin and syndecan -1 level in the patients with mesothelioma, metastatic malignant pleural diseases, benign pleural diseases, and benign asbestos pleurisy.
Sponsors and Collaborators:
Eskisehir Osmangazi University
Website Link: https://ClinicalTrials.gov/show/NCT02029105
